Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.74 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.74 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.74 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5018909 | 0.89 | TAAR1 (0.59) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| Machilin A SCHEMBL10343221 | 0.89 | TAAR1 (0.74) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| Machilin A SCHEMBL31237868 | 0.89 | TAAR1 (0.74) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| Machilin A SCHEMBL30678762 | 0.89 | TAAR1 (0.74) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL23046948 | 0.86 | TAAR1 (0.66) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| Tenamfetamine SCHEMBL9361151 | 0.85 | TAAR1 (1.00) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL18462066 | 0.85 | TAAR1 (0.70) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL21791708 | 0.85 | TAAR1 (0.70) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL12775573 | 0.85 | TAAR1 (0.56) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL25075019 | 0.85 | TAAR1 (0.70) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103562169-A | Purification process for para-methallylpyrocatechol | FMC CORP | 2014-02-05 | — | — | CN | claimed |
| EP-2563508-A2 | DELIVERY PARTICLE | The Procter & Gamble Company (US) | 2013-03-06 | — | — | EP | claimed |
| WO-2010079468-A2 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | claimed |
| CN-122028974-A | Ribonucleic acid-based microcapsules | 弗门尼舍有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-120136648-A | Direct reduction method of alkyl alcohol or aldehyde ketone substrate | 浙江理工大学嵊州创新研究院有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120115098-A | Method for producing polyamide microcapsules | 弗门尼舍有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-120091807-A | Lipid-based microcapsules | 弗门尼舍有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-120076721-A | Wax-based microcapsules | 弗门尼舍有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119923291-A | Mixed microcapsules | 弗门尼舍有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119562853-A | Composite microcapsule | 弗门尼舍有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119173334-A | Polyamide microcapsule | 弗门尼舍有限公司 | 2024-12-20 | — | — | CN | disclosed |
| WO-2007002172-A2 | HIV-1 PROTEASE INHIBITORS | UNIVERSITY OF MASSACHUSETTS (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20070004729-A1 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. | 2007-01-04 | — | — | US | disclosed |
| WO-2007002173-A1 | HIV-1 PROTEASE INHIBITORS, AND METHODS OF MAKING AND USING THEM | UNIVERSITY OF MASSACHUSETTS (US) | 2007-01-04 | — | — | WO | disclosed |
| WO-2006128184-A2 | PYRIMIDINE OR TRIAZINE FUSED BICYCLIC METALLOPROTEASE INHIBITORS | ALANTOS-PHARMACEUTICALS, INC. (US) | 2006-11-30 | — | — | WO | disclosed |
| WO-2005068437-A1 | 2, 4 - DIAMINOPYRIMIDINES AND THEIR USE FOR INDUCING CARDIOMYOGENESIS | NOVARTIS AG (CH) | 2005-07-28 | — | — | WO | disclosed |
| EP-1392679-A1 | NOVEL 1-AMIDOMETHYLCARBONYL-PIPERIDINE DERIVATIVES, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING SAID COMPOUNDS | Solvay Pharmaceuticals GmbH (DE) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002092592-A1 | NOVEL 1-AMIDOMETHYLCARBONYL-PIPERIDINE DERIVATIVES, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING SAID COMPOUNDS | SOLVAY PHARMACEUTICALS GMBH (DE) | 2002-11-21 | — | — | WO | disclosed |
| US-4058607-A | DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES | AIRWICK INDUSTRIES, INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-3962415-A | Insecticide evaporator comprising DDVP with synergized benzodioxole compound as stabilizer | AIRWICK INDUSTRIES, INC. (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004729-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | TAAR1 2382/4885SLC6A4 4750/4885SLC6A2 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.